FDAClass IIJune 26, 2024

Cefixime for Oral Suspension USP 200 mg/5 mL recall

Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.…

Why was Cefixime for Oral Suspension USP 200 mg/5 mL recalled?

Failed Content Uniformity Specifications

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

Lot F201519, Expiry: November 2024

Product
Cefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc.…
Recalling firm
Lupin Pharmaceuticals Inc.
Quantity
3,552 bottles
Distribution
Nationwide in the US
Recall date
June 26, 2024
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls